|
Market Closed -
OTC Markets
03:51:35 19/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0225 USD | -2.17% |
|
-0.66% | -13.46% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Biopharmaceuticals | -2.17% | -0.66% | -13.46% | -84.42% | -99.58% | 5.96M |
-
|
-
|
-
|
- Stock Market
- Stocks
- ADAPY Stock
- Charts Adaptimmune Therapeutics plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
